159 related articles for article (PubMed ID: 16645534)
1. Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: a double-blind controlled pilot study.
Dias RS; Kerr-Corrêa F; Moreno RA; Trinca LA; Pontes A; Halbe HW; Gianfaldoni A; Dalben IS
Menopause; 2006; 13(2):202-11. PubMed ID: 16645534
[TBL] [Abstract][Full Text] [Related]
2. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
Schatzberg A; Roose S
Am J Geriatr Psychiatry; 2006 Apr; 14(4):361-70. PubMed ID: 16582045
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Gee MD; Krishen A; Wunderlich HP; Le Clus A; Evoniuk G; Modell JG
J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.
Stahl SM; Entsuah R; Rudolph RL
Biol Psychiatry; 2002 Dec; 52(12):1166-74. PubMed ID: 12488062
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
7. Venlafaxine extended-release: a review of its use in the management of major depression.
Wellington K; Perry CM
CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
[TBL] [Abstract][Full Text] [Related]
8. Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind study.
Wang G; Gislum M; Filippov G; Montgomery S
Curr Med Res Opin; 2015 Apr; 31(4):785-94. PubMed ID: 25650503
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.
Costa e Silva J
J Clin Psychiatry; 1998 Jul; 59(7):352-7. PubMed ID: 9714263
[TBL] [Abstract][Full Text] [Related]
10. Once- versus twice-daily venlafaxine therapy in major depression: a randomized, double-blind study.
Amsterdam JD; Hooper MB; Amchin J
J Clin Psychiatry; 1998 May; 59(5):236-40. PubMed ID: 9632034
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care.
Lenox-Smith AJ; Reynolds A
Br J Gen Pract; 2003 Oct; 53(495):772-7. PubMed ID: 14601352
[TBL] [Abstract][Full Text] [Related]
12. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
[TBL] [Abstract][Full Text] [Related]
13. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.
Einarson TR; Arikian SR; Casciano J; Doyle JJ
Clin Ther; 1999 Feb; 21(2):296-308. PubMed ID: 10211533
[TBL] [Abstract][Full Text] [Related]
14. Escitalopram versus venlafaxine XR in the treatment of depression.
Montgomery SA; Andersen HF
Int Clin Psychopharmacol; 2006 Sep; 21(5):297-309. PubMed ID: 16877901
[TBL] [Abstract][Full Text] [Related]
15. Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study.
McIntyre A; Gendron A; McIntyre A
Depress Anxiety; 2007; 24(7):487-94. PubMed ID: 17177199
[TBL] [Abstract][Full Text] [Related]
16. [Venlafaxine in the treatment of moderate and severe depressions: the ways to increase treatment efficacy].
Ivanets NN; Kinkulkina MA; Tikhonova YG; Iziumina TA
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):30-34. PubMed ID: 25909786
[TBL] [Abstract][Full Text] [Related]
17. Androgens and menopause: more fuel for the fire.
Shulman LP
Menopause; 2006; 13(2):168-70. PubMed ID: 16645529
[No Abstract] [Full Text] [Related]
18. The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group.
Khan A; Upton GV; Rudolph RL; Entsuah R; Leventer SM
J Clin Psychopharmacol; 1998 Feb; 18(1):19-25. PubMed ID: 9472838
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
Nemeroff CB; Thase ME;
J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
[TBL] [Abstract][Full Text] [Related]
20. A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.
Mazeh D; Shahal B; Aviv A; Zemishlani H; Barak Y
Int Clin Psychopharmacol; 2007 Nov; 22(6):371-5. PubMed ID: 17917556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
